Table 2:
Dominance analysis for HIV-related and mental health correlates of perceived health and functional disability
A: Health Perception | ||||
---|---|---|---|---|
CES-D | Davidson | Viral Load | Total R2 | |
GD Weight (%) | 0.177* (69.9%) | 0.040 (15.8%) | 0.036 (14.2%) | 0.253 |
95% CI | (0.038, 0.316) | (−0.043, 0.115) | (−0.075, −0.155) | |
B: Health Perception | ||||
CES-D | Davidson | CD4 Count | R 2 | |
GD Weight (%) | 0.204* (91.5%) | 0.018 (8.1%) | 0.001 (0.4%) | .223 |
95% CI | (0.056, 0.352) | (−0.064, 0.099) | (−0.108, 0.110) | |
C: Functional Disability | ||||
CES-D | Davidson | Viral Load | R 2 | |
GD Weight (%) | 0.119 (38.6%) | 0.170* (55.2%) | 0.019 (6.2%) | .308 |
95% CI | (−0.017, 0.254) | (0.044, 0.296) | (−0.036, 0.072) | |
D: Functional Disability | ||||
CES-D | Davidson | CD4 Count | R 2 | |
GD Weight (%) | 0.165* (42.5%) | 0.173* (44.6%) | 0.050 (12.9%) | .388 |
95% CI | (0.046, 0.284) | (0.034, 0.312) | (−0.059, 0.158) |
GD weight = general dominance weight; 95% CI = 95% confidence intervals. % = the proportion of R2 accounted for. This proportion is derived from the ratio of the general dominance weight to the total R2.
p < 0.05.
Models A and C examine CES-D and DTS relative to HIV RNA viral suppression status, whereas models B and D examine these psychological symptom measures in relation to CD4 count.